Seoane Asunción, Sánchez Emilia, García-Lobo Juan M
Departamento de Biología Molecular, Unidad Asociada al CIB, CSIC, Facultad de Medicina, Universidad de Cantabria, Cardenal Herrera Oria s/n, 3901-Santander, Spain.
Antimicrob Agents Chemother. 2003 Feb;47(2):682-8. doi: 10.1128/AAC.47.2.682-688.2003.
Most Yersinia enterocolitica strains are resistant to beta-lactam antibiotics due to the production of one or two chromosomally encoded beta-lactamases. Strain Y56 is a Y. enterocolitica O:3 serotype natural isolate that is resistant to moderate amounts of penicillins and that produces a single class A beta-lactamase. To select mutants with increased levels of resistance to beta-lactam antibiotics, strain Y56 was grown on plates containing increasing amounts of ampicillin, and variants resistant to up to 500 micro g of ampicillin per ml were obtained. Chromosomal DNA from hyperresistant isolates was analyzed by Southern hybridization with a blaA-specific probe to detect gene rearrangements. The use of pulsed-field gel electrophoresis revealed that the increase in the resistance level correlated with the amplification in tandem of a DNA fragment of about 28 kb containing the blaA gene. The phenotype of these isolates was not stable, and they recovered the basal low resistance level when the ampicillin used for selection was withdrawn from the growth medium. This loss of resistance was followed by the recovery of the original chromosomal structure. To understand this amplification process, the 28-kb amplification unit was cloned, and the ends were sequenced. The analysis of these sequences did not reveal the presence of either repeats or transposable elements to explain this process. However, we found short sequences similar to some DNA gyrase target sequences that have been described. In addition, we observed that the frequency of appearance of ampicillin-hyperresistant isolates by amplification of the blaA locus was lowered in the presence of the gyrase inhibitor novobiocin. These findings suggest that the DNA gyrase could be involved in this amplification event.
大多数小肠结肠炎耶尔森菌菌株由于产生一种或两种染色体编码的β-内酰胺酶而对β-内酰胺类抗生素耐药。菌株Y56是小肠结肠炎耶尔森菌O:3血清型的天然分离株,对适量青霉素耐药,并产生单一的A类β-内酰胺酶。为了筛选对β-内酰胺类抗生素耐药性增强的突变体,将菌株Y56在含有递增浓度氨苄青霉素的平板上培养,获得了对每毫升高达500μg氨苄青霉素耐药的变体。用blaA特异性探针通过Southern杂交分析超耐药分离株的染色体DNA,以检测基因重排。脉冲场凝胶电泳的结果显示,耐药水平的提高与包含blaA基因的约28kb DNA片段的串联扩增相关。这些分离株的表型不稳定,当从生长培养基中撤去用于筛选的氨苄青霉素时,它们恢复到基础低耐药水平。耐药性的丧失伴随着原始染色体结构的恢复。为了了解这种扩增过程,克隆了28kb的扩增单元并对其末端进行了测序。对这些序列的分析未发现存在重复序列或转座元件来解释这一过程。然而,我们发现了与一些已描述的DNA回旋酶靶序列相似的短序列。此外,我们观察到在存在回旋酶抑制剂新生霉素的情况下,blaA基因座扩增产生氨苄青霉素超耐药分离株的频率降低。这些发现表明DNA回旋酶可能参与了这一扩增事件。